 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | CD30 biAb-AATC / Medical College of Wisconsin, Tundra Targeted Therap
New P1/2 trial: CD30biAb-AATC for CD30+ Malignancies (clinicaltrials.gov) - Sep 19, 2022
P1/2, N=42, Not yet recruiting, Sponsor: Medical College of Wisconsin